Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06177535 · ClinicalTrials.gov registry record · NA

A Study of Oral Kavalactones Effect on Nurses

A NA study of Stress, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06177535: Recruiting NA study of Stress, sponsored by Mayo Clinic.

NCT06177535 is a NA study of Stress that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 200 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06177535, a NA study of Stress, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This research study is being done to assess the impact of taking Kava extract (Piper methysticum), a dietary supplement on cortisol in a healthy nursing population.

Primary Outcome

Blood serum cortisol levels reported in micrograms per deciliter (mcg/dL)

Conditions Studied

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT Kavalactones

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-08-05
Est. Completion 2026-06-30
Phase NA
Mayo Clinic

2,844 total trials

What NCT06177535 shows while recruiting

NCT06177535 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06177535 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06177535 about?

NCT06177535 is a clinical study titled "A Study of Oral Kavalactones Effect on Nurses". This research study is being done to assess the impact of taking Kava extract (Piper methysticum), a dietary supplement on cortisol in a healthy nursing population.

What is the current status of trial NCT06177535?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-08-05. Estimated completion is 2026-06-30.

What conditions does trial NCT06177535 study?

This clinical trial studies the following conditions: Stress.

What interventions are being tested in trial NCT06177535?

The interventions under investigation include: Placebo (DRUG), Kavalactones (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06177535?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06177535 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06177535's enrollment target sits among peer trials

200 29th of 152 higher than 123 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06177535, the US trial registry maintained by the National Library of Medicine. NCT06177535 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.